233 related articles for article (PubMed ID: 11934320)
21. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
[TBL] [Abstract][Full Text] [Related]
22. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.
Busam KJ; Iversen K; Coplan KC; Jungbluth AA
Am J Surg Pathol; 2001 Feb; 25(2):197-204. PubMed ID: 11176068
[TBL] [Abstract][Full Text] [Related]
23. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
24. Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases.
Gupta D; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2004 Jun; 28(6):771-80. PubMed ID: 15166669
[TBL] [Abstract][Full Text] [Related]
25. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
[TBL] [Abstract][Full Text] [Related]
26. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.
de Vries TJ; Trancikova D; Ruiter DJ; van Muijen GN
Br J Cancer; 1998 Nov; 78(9):1156-61. PubMed ID: 9820172
[TBL] [Abstract][Full Text] [Related]
27. S100, HMB-45, and Melan-A negative primary melanoma.
Shinohara MM; Deubner H; Argenyi ZB
Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
Liegl B; Hornick JL; Fletcher CD
Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
[TBL] [Abstract][Full Text] [Related]
29. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
Gajjar NA; Cochran AJ; Binder SW
Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
[TBL] [Abstract][Full Text] [Related]
30. Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum.
Stone CH; Lee MW; Amin MB; Yaziji H; Gown AM; Ro JY; Têtu B; Paraf F; Zarbo RJ
Arch Pathol Lab Med; 2001 Jun; 125(6):751-8. PubMed ID: 11371226
[TBL] [Abstract][Full Text] [Related]
31. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
32. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R
Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma.
Alaeddini M; Etemad-Moghadam S
J Oral Pathol Med; 2015 Mar; 44(3):234-8. PubMed ID: 25048051
[TBL] [Abstract][Full Text] [Related]
35. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study.
Makhlouf HR; Ishak KG; Shekar R; Sesterhenn IA; Young DY; Fanburg-Smith JC
Arch Pathol Lab Med; 2002 Jan; 126(1):49-55. PubMed ID: 11800647
[TBL] [Abstract][Full Text] [Related]
36. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
37. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of S-100 beta in choroidal melanomas.
Martins MC; Scull JJ; Alcocer CE; Deschênes J; Antecka E; Burnier MN
Can J Ophthalmol; 1997 Oct; 32(6):378-81. PubMed ID: 9363341
[TBL] [Abstract][Full Text] [Related]
39. Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fisher DE
Appl Immunohistochem Mol Morphol; 2002 Mar; 10(1):47-51. PubMed ID: 11893035
[TBL] [Abstract][Full Text] [Related]
40. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
Plótár V; Szentirmay Z; Orosz Z
Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
